{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-023258","form_type":"8-K","ticker":"BIXT","cik":"0001445815","company_name":"BIOXYTRAN, INC","filed_at":"2022-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.797017+00:00","generated_at":"2026-06-23T23:06:00.720305+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bioxytran raises $600K in private placement for Covid-19, lung fibrosis clinical trials","bullets":["Issued 1.4M shares at $0.4286/share to an accredited investor for gross proceeds of $600,000.","Net proceeds of $576,000 after 4% placement agent fee paid to WallachBeth Capital.","Proceeds intended for down-payment on human trials of ProLectin-M (oral) for Covid-19 and ProLectin-I (IV) for lung fibrosis.","Shares offered on best-efforts basis; no minimum offering amount; funds available immediately upon acceptance."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-023258","json":"https://secwatch.observer/filing/0001493152-22-023258.json","markdown":"https://secwatch.observer/filing/0001493152-22-023258.md","text":"https://secwatch.observer/filing/0001493152-22-023258.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445815/000149315222023258/0001493152-22-023258-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445815/000149315222023258/form-8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:06:00.720305+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}